CN102292432B - 鸡败血支原体制剂 - Google Patents

鸡败血支原体制剂 Download PDF

Info

Publication number
CN102292432B
CN102292432B CN2010800052398A CN201080005239A CN102292432B CN 102292432 B CN102292432 B CN 102292432B CN 2010800052398 A CN2010800052398 A CN 2010800052398A CN 201080005239 A CN201080005239 A CN 201080005239A CN 102292432 B CN102292432 B CN 102292432B
Authority
CN
China
Prior art keywords
mycoplasma gallisepticum
bacterial strain
birds
mycoplasma
strain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN2010800052398A
Other languages
English (en)
Chinese (zh)
Other versions
CN102292432A (zh
Inventor
S.H.克莱文
N.M.费尔古森
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Georgia Research Foundation Inc
Original Assignee
University of Georgia Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Georgia Research Foundation Inc filed Critical University of Georgia Research Foundation Inc
Publication of CN102292432A publication Critical patent/CN102292432A/zh
Application granted granted Critical
Publication of CN102292432B publication Critical patent/CN102292432B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/35—Mycoplasma
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/87—Mycoplasma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CN2010800052398A 2009-01-22 2010-01-22 鸡败血支原体制剂 Active CN102292432B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14647209P 2009-01-22 2009-01-22
US61/146472 2009-01-22
PCT/US2010/021749 WO2010085611A2 (en) 2009-01-22 2010-01-22 Mycoplasma gallisepticum formulation

Publications (2)

Publication Number Publication Date
CN102292432A CN102292432A (zh) 2011-12-21
CN102292432B true CN102292432B (zh) 2013-05-22

Family

ID=42356391

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010800052398A Active CN102292432B (zh) 2009-01-22 2010-01-22 鸡败血支原体制剂

Country Status (9)

Country Link
US (1) US8668912B2 (https=)
EP (1) EP2389433B1 (https=)
JP (1) JP5642710B2 (https=)
KR (1) KR101715159B1 (https=)
CN (1) CN102292432B (https=)
BR (1) BRPI1006947B1 (https=)
CA (1) CA2749213C (https=)
MX (1) MX2011007732A (https=)
WO (1) WO2010085611A2 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2943219T4 (pl) * 2012-09-10 2022-08-22 Susan Szathmary Szczepionka do zapobiegania zakażeniu mykoplazmalnemu u ptactwa wodnego
CN106967829A (zh) * 2017-05-18 2017-07-21 隋兆峰 一种鉴别mg 6/85株的套式pcr检测方法
CN110218808B (zh) * 2019-06-28 2021-07-13 华中农业大学 滑液囊支原体和鸡毒支原体的四重pcr检测试剂盒
CN119816588A (zh) * 2022-04-06 2025-04-11 乔治亚大学研究基金公司 鸡毒支原体活疫苗
US20260014240A1 (en) * 2022-07-20 2026-01-15 University Of Connecticut Rationally designed mycoplasma gallisepticum subunit vaccine
CN118078972B (zh) * 2024-03-07 2024-10-22 佛山大学 一种鹅源鸡毒支原体灭活疫苗及其制备方法和应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040009179A1 (en) * 2002-07-13 2004-01-15 Kleven Stanley H. Mycoplasma gallisepticum formulation
US20060252110A1 (en) * 2002-08-27 2006-11-09 Christopher Gregory Assays for the detection of biliverdin in birds and reptiles
US20070178115A1 (en) * 2005-08-15 2007-08-02 Tang De-Chu C Immunization of avians by administration of non-replicating vectored vaccines

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5196514A (en) 1990-03-06 1993-03-23 The University Of Georgia Research Foundation, Inc. Method of detecting mycoplasma infection in poultry and compositions therefor
WO1993001276A1 (en) 1991-07-12 1993-01-21 Smithkline Beecham Corporation Continuous cell line and vaccine against avian coccidia

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040009179A1 (en) * 2002-07-13 2004-01-15 Kleven Stanley H. Mycoplasma gallisepticum formulation
US20060252110A1 (en) * 2002-08-27 2006-11-09 Christopher Gregory Assays for the detection of biliverdin in birds and reptiles
US20070178115A1 (en) * 2005-08-15 2007-08-02 Tang De-Chu C Immunization of avians by administration of non-replicating vectored vaccines

Also Published As

Publication number Publication date
HK1161289A1 (zh) 2012-08-24
BRPI1006947A2 (pt) 2016-10-04
CA2749213A1 (en) 2010-07-29
BRPI1006947B1 (pt) 2020-02-04
WO2010085611A2 (en) 2010-07-29
CA2749213C (en) 2017-08-15
KR20110123748A (ko) 2011-11-15
KR101715159B1 (ko) 2017-03-10
US8668912B2 (en) 2014-03-11
EP2389433A2 (en) 2011-11-30
WO2010085611A3 (en) 2010-11-25
CN102292432A (zh) 2011-12-21
MX2011007732A (es) 2011-11-04
EP2389433B1 (en) 2015-11-25
JP5642710B2 (ja) 2014-12-17
US20120021005A1 (en) 2012-01-26
JP2012515552A (ja) 2012-07-12
EP2389433A4 (en) 2012-10-17

Similar Documents

Publication Publication Date Title
CN106947746B (zh) 鸡传染性支气管炎致弱疫苗株ldl-t株及其应用
CN102458462B (zh) 一种温度敏感的猪肺炎支原体疫苗株及其应用
CN101827605B (zh) 牛支原体疫苗
CN102292432B (zh) 鸡败血支原体制剂
CN119816588A (zh) 鸡毒支原体活疫苗
CN114854654B (zh) 一种肠炎沙门氏菌活疫苗
US7217420B2 (en) Mycoplasma gallisepticum formulation
CN108251338B (zh) 猪鼻支原体强毒株及其应用
KR101360112B1 (ko) 공기전파가 가능한 신규한 ｈ９ｎ２형 저병원성 조류인플루엔자 바이러스 균주 및 그로부터 유래된 백신
HK1161289B (en) Mycoplasma gallisepticum formulation
CN110713987A (zh) 一种重组基因vii型新城疫病毒毒株及其疫苗组合物、制备方法及应用
Behboudi Turkey Rhinotracheitis
Liu et al. A newly developed temperature-sensitive Mycoplasma synoviae live attenuated strain prevents pathological lesions of the respiratory and reproductive tracts in chickens caused by a wild-type M. synoviae strain
Raheem et al. Continental Veterinary Journal
CN118891358A (zh) 鸡滑液囊支原体活疫苗
Oliveira Haemophilus parasuis: diagnosis, epidemiology and control
Armour An evaluation of the molecular epidemiology and transmission of avian mycoplasma genotypes in commercial poultry
Alkhalaf et al. Isolation of Mycoplasma gallisepticum and Mycoplasma synoviae from native, Ross and Lohmann chickens in Hail region of Saudi Arabia
Ferguson The evaluation of a live Mycoplasma gallisepticum vaccine candidate and DNA sequence analysis in the molecular epidemiology of Mycoplasma gallisepticum
Alkhalaf Pathogenicity and antigenicity of an American avian pneumovirus

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant